<code id='A162633BBA'></code><style id='A162633BBA'></style>
    • <acronym id='A162633BBA'></acronym>
      <center id='A162633BBA'><center id='A162633BBA'><tfoot id='A162633BBA'></tfoot></center><abbr id='A162633BBA'><dir id='A162633BBA'><tfoot id='A162633BBA'></tfoot><noframes id='A162633BBA'>

    • <optgroup id='A162633BBA'><strike id='A162633BBA'><sup id='A162633BBA'></sup></strike><code id='A162633BBA'></code></optgroup>
        1. <b id='A162633BBA'><label id='A162633BBA'><select id='A162633BBA'><dt id='A162633BBA'><span id='A162633BBA'></span></dt></select></label></b><u id='A162633BBA'></u>
          <i id='A162633BBA'><strike id='A162633BBA'><tt id='A162633BBA'><pre id='A162633BBA'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:5
          Amylyx founders
          Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

          The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

          Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

          advertisement

          The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Beware the threat of staffing cuts at the CDC
          Beware the threat of staffing cuts at the CDC

          DavidGoldman/APThenation’shealthfacesadualthreat—oneanticipated,theother,self-inflicted.Covid-19hasn

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Bird flu outbreak in cows is latest avian flu curveball

          MollyFergusonforSTATTwenty-sevenyearsagotoday,a3-year-oldboyinHongKongdevelopedasorethroat,spikedafe